Figure 2From: Cardiac involvement in cardiac AL amyloidosis as measured by equilibrium contrast cardiovascular magnetic resonancecompares the mean VDm between normals (group 1) and Systemic AL Amyloidosis patients with : No suspected cardiac involvement (group 2, P=0.44), possible cardiac involvement (group 3, P<0.001) and definite cardiac involvement (group 4, P<0.001).Back to article page